{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-043989","form_type":"8-K","ticker":"VTGN","cik":"0001411685","company_name":"Vistagen Therapeutics, Inc.","filed_at":"2026-06-17T21:13:49+00:00","discovered_at":"2026-06-17T21:16:00.270544+00:00","generated_at":"2026-06-17T21:16:35.895234+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Two Vistagen directors will not stand for re-election at 2026 Annual Meeting","bullets":["Margaret FitzPatrick (June 16) and Joanne Curley (June 17) notified Vistagen they will not stand for re-election.","Both will continue serving as directors until the end of their terms at the 2026 Annual Meeting.","No replacements have been announced; board composition will change after the meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-043989","json":"https://secwatch.observer/filing/0001628280-26-043989.json","markdown":"https://secwatch.observer/filing/0001628280-26-043989.md","text":"https://secwatch.observer/filing/0001628280-26-043989.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1411685/000162828026043989/0001628280-26-043989-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1411685/000162828026043989/vtgn-20260616.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T21:16:35.895234+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"7961047101","claim":"Joanne Curley departed as Director at Vistagen Therapeutics, Inc..","evidence_excerpt":"On June 16, 2026, Ms. Margaret FitzPatrick, and on June 17, 2026, Dr. Joanne Curley, each a member of the Board of Directors of Vistagen Therapeutics, Inc. (the “ Company ”), notified the Company of her decision not to stand for re-election at the Company’s 2026 Annual Meeting of Stockholders.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1411685/000162828026043989/0001628280-26-043989-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"not stand for re-election"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"f17e8b23cc","claim":"Margaret FitzPatrick departed as Director at Vistagen Therapeutics, Inc..","evidence_excerpt":"On June 16, 2026, Ms. Margaret FitzPatrick, and on June 17, 2026, Dr. Joanne Curley, each a member of the Board of Directors of Vistagen Therapeutics, Inc. (the “ Company ”), notified the Company of her decision not to stand for re-election at the Company’s 2026 Annual Meeting of Stockholders.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1411685/000162828026043989/0001628280-26-043989-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"not stand for re-election"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}